Details

Vloga imunoproteasoma v celicah kronične limfocitne levkemije : enoviti magistrski študijski program Farmacija
ID Temeljotov, Ana (Author), ID Mlinarič-Raščan, Irena (Mentor) More about this mentor... This link opens in a new window, ID Markovič, Tijana (Comentor)

URLURL - Presentation file, Visit http://www.ffa.uni-lj.si/docs/default-source/knjiznica-doc/magistrske/2018/temeljotov_ana_mag_2018.pdf?sfvrsn=2 This link opens in a new window

Language:Slovenian
Keywords:kronična limfocitna levkemija, inhibitorji imunoproteasoma, inhibitorji proteasoma, ONX-0914 (PR-957), celične kulture, levkemija
Work type:Master's thesis/paper
Typology:2.09 - Master's Thesis
Organization:FFA - Faculty of Pharmacy
Place of publishing:Ljubljana
Publisher:[A. Temeljotov]
Year:2018
Number of pages:VII, 60 f., I-VI f. pril.
PID:20.500.12556/RUL-102118 This link opens in a new window
UDC:616.155.392-085:615.2(043.3)
COBISS.SI-ID:4531313 This link opens in a new window
Publication date in RUL:12.10.2019
Views:21915
Downloads:222
Metadata:XML DC-XML DC-RDF
:
TEMELJOTOV, Ana, 2018, Vloga imunoproteasoma v celicah kronične limfocitne levkemije : enoviti magistrski študijski program Farmacija [online]. Master’s thesis. Ljubljana : A. Temeljotov. [Accessed 6 June 2025]. Retrieved from: http://www.ffa.uni-lj.si/docs/default-source/knjiznica-doc/magistrske/2018/temeljotov_ana_mag_2018.pdf?sfvrsn=2
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:The role of the immunoproteasome in chronic lymphocytic leukemia cells

Similar documents

Similar works from RUL:
  1. Investigation of venetoclax resistance mechanisms in chronic lymphocytic leukemia cells
  2. Synergistic effects of ibrutinib and idelalisib with EP4 receptor agonists on chronic lymphocytic leukemia cells
  3. The role of autophagy in the therapeutic susceptibility of chronic lymphocytic leukemia cells
  4. Identification of programmed cell death modulators in chronic lymphocytic leukemia cells
  5. EP4 receptor agonist L-902688 augments cytotoxic activities of ibrutinib, idelalisib, and venetoclax against chronic lymphocytic leukemia cells
Similar works from other Slovenian collections:
  1. Chronic leukemias
  2. Akutne levkemije
  3. Klasifikacija malignih limfomov
  4. Preživetje bolnikov z rakom v Sloveniji - novosti iz Registra raka za Slovenijo za obdobje 1988-1997
  5. Prevention and treatment of complications of chronic lymphocytic leukemia (Case presentation)

Back